| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NX | Common Stock | Options Exercise | $31,665 | +1,500 | +5.4% | $21.11 | 29,473 | 03 Jan 2022 | Direct | F1, F2 |
| transaction | NX | Common Stock | Sale | $37,500 | -1,500 | -5.1% | $25.00 | 27,973 | 03 Jan 2022 | Direct | F1, F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NX | Stock Options (Right to Buy) | Options Exercise | $0 | -1,500 | -100% | $0.000000* | 0 | 03 Jan 2022 | Common Stock | 1,500 | $21.11 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The stock options were exercised pursuant to a Rule 10b5-1 preset diversification program previously adopted by the reporting person in July 2021. |
| F2 | Includes 12.99 shares credited to the reporting person's account as the result of prior dividend reinvestments under the Company's Employee Stock Purchase Plan. |
| F3 | The options became exercisable in 1/3 increments annually beginning one year from the grant date. |